拜尔德医疗股价创历史新低，年初至今累计跌幅超40%

Core Viewpoint - Baird Medical (BDMD.OQ) has experienced a significant decline in stock price over the past week, raising market concerns about its financial health and investor confidence [1][2] Group 1: Stock Performance - On February 12, 2026, the closing price was $0.80, with a daily drop of 4.76%, reaching a historical low of $0.77 during intraday trading, and a total trading volume of $85,200 [1] - Year-to-date, the cumulative decline has reached 41.17%, indicating a severe downturn in stock performance [1] - The stock experienced a 13.04% drop over the past week, with a trading range volatility of 31.30% [1] Group 2: Market Context - On February 11, 2026, the stock price fell by over 8% without any major announcements from the company, reflecting investor concerns over its ongoing losses [2] - The medical device sector saw a slight increase of 0.07% on the same day, while the Nasdaq index decreased by 0.04%, highlighting the company's underperformance compared to its peers [2] - The company's price-to-earnings ratio (TTM) is negative at -7.55, indicating a continued state of losses and low liquidity, which can lead to significant price fluctuations [1]